Senators question tobacco firms on lobbying in wake of new FDA policy

A group of six Democratic senators sent letters to two tobacco companies on Thursday, asking for details on their dealings with the Trump administration in the wake of the Food and Drug Administration (FDA) easing vaping restrictions.  Last month, the FDA granted marketing authorization to four flavored vaping products and issued new guidance allowing unauthorized…

spot_imgspot_img

Subscribe

Related articles

spot_imgspot_img